{"id":692,"date":"2012-10-08T14:49:23","date_gmt":"2012-10-08T14:49:23","guid":{"rendered":"https:\/\/blogs.bmj.com\/spcare\/?p=692"},"modified":"2012-10-08T14:49:23","modified_gmt":"2012-10-08T14:49:23","slug":"news-and-updates-from-www-palliativedrugs-com-29","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/spcare\/2012\/10\/08\/news-and-updates-from-www-palliativedrugs-com-29\/","title":{"rendered":"News and updates from www.palliativedrugs.com"},"content":{"rendered":"<p><strong><em>Selected items from the News and Latest Additions sections of <a href=\"http:\/\/www.palliativedrugs.com\/\">www.palliativedrugs.com<\/a>, the world\u2019s leading palliative care website.<\/em><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Drug updates<\/strong><\/p>\n<p><strong>NICE final draft guidance for denosumab<\/strong><\/p>\n<p>The UK National Institute for Health and Clinical Excellence (NICE) has published final draft guidance on the use of denosumab for the treatment of bone metastases from solid tumours and multiple myeloma. It makes the following recommendations:<\/p>\n<ul>\n<li>denosumab is recommended as an option for preventing skeletal-related events in adults with bone metastases from breast cancer and from solid tumours (other than breast and prostate) if bisphosphonates would otherwise be prescribed and the manufacturer provides denosumab with the discount agreed in the patient access scheme<\/li>\n<li>denosumab is not recommended for preventing skeletal-related events in adults with bone metastases from prostate cancer.<\/li>\n<\/ul>\n<p>For more information click <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.nice.org.uk\/nicemedia\/live\/12177\/60614\/60614.pdf\">here<\/a><\/span>.<strong><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>FDA authorize tapentadol m\/r for neuropathic pain<\/strong><\/p>\n<p>US Food and Drug Administration (FDA) have authorized tapentadol m\/r tablets (Nucynta ER; Janssen Pharmaceuticals, Titusville, New Jersey) for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. For full prescribing details click <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.nucynta.com\/sites\/default\/files\/pdf\/nucyntaer-pi.pdf#zoom=100\">here<\/a><\/span>.<strong><\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Latest additions<\/strong><\/p>\n<p><strong>PCF dihydrocodeine monograph updated<\/strong><\/p>\n<p>The Palliative Care Formulary (PCF) <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/dihydrocodeine.html\">dihydrocodeine tartrate<\/a><\/span>\u00a0monograph has been updated. The current version (updated August 2012) can now be accessed from the formulary section of the website and supersedes the printed PCF4 book version.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>PCF weak opioids monograph updated<\/strong><\/p>\n<p>The Palliative Care Formulary (PCF) <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/formulary\/en\/weak-opioids.html\">weak opioids<\/a><\/span>\u00a0monograph has been updated. The current version (updated August 2012) can now be accessed from the formulary section of the website and supersedes the printed PCF4 book version.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Die Juli\/August Ausgabe des APM Newsletter ist fertig<\/strong><\/p>\n<p>The <span style=\"text-decoration: underline\"><a href=\"http:\/\/www.palliativedrugs.com\/download\/APM%20Newsletter42012f.pdf\">July\/August<\/a><\/span>\u00a0issue of APM Newsletter for German-speaking users of www.palliativedrugs.com is available.<\/p>\n<p>Die<a href=\"http:\/\/www.palliativedrugs.com\/download\/APM%20Newsletter42012f.pdf\"> <span style=\"text-decoration: underline\">Juli\/August<\/span><\/a>\u00a0Ausgabe des APM Newsletter ist fertig. \u00dcber die aktuelle Ausgaben des Newsletters wird Sie das Bulletin Board informieren.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>Prepared by Sarah Charlesworth and Andrew Wilcock<\/em><!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world\u2019s leading palliative care website. &nbsp; Drug updates NICE final draft guidance for denosumab The UK National Institute for Health and Clinical Excellence (NICE) has published final draft guidance on the use of denosumab for the treatment of bone metastases from solid tumours [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/spcare\/2012\/10\/08\/news-and-updates-from-www-palliativedrugs-com-29\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":157,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2833],"tags":[],"class_list":["post-692","post","type-post","status-publish","format-standard","hentry","category-updates-from-www-palliativedrugs-com"],"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/users\/157"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/comments?post=692"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/posts\/692\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/media?parent=692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/categories?post=692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/spcare\/wp-json\/wp\/v2\/tags?post=692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}